Remove tag 2023-predictions
article thumbnail

Chocolate Shortage Looms Ahead of Easter 2024

XTalks

Related: Why the UK is Facing a Tomato Shortage in 2023 Chocolate Makers Feel the Pinch With the likelihood of a fourth consecutive poor growing season, chocolate manufacturers like Hershey and Mondelez (owners of Cadbury) are forced to raise prices to offset the rising cost of cocoa.

article thumbnail

2023 Farm Bill: What Lawmakers are Hoping to Achieve in Agriculture, Nutrition and Beyond

XTalks

The 2023 Farm Bill is the comprehensive package that US Congress uses to set national agriculture, conservation, nutrition and forestry policy. Special interests are lining up for their slice of the bill, which will replace the five-year-old 2018 Farm Bill set to expire on October 1st, 2023.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds June 9, 2023: Emulating Randomized Clinical Trials with Non-randomized Real-world Evidence Studies: Results From The RCT DUPLICATE Initiative (Shirley V. Wang, PhD)

Rethinking Clinical Trials

The first aim of the project is to use healthcare databases to emulate the design of 30 completed trials and predict the results of 7 ongoing trials. The third aim is to evaluate factors that predict concordance between the trials and the databases. Wang, PhD) appeared first on Rethinking Clinical Trials.

article thumbnail

Grand Rounds June 2, 2023: PROACT Xa and The Wizard of Oz: Behind the Curtain of a Pragmatic Decentralized Clinical Trial (John Alexander, MD, MHS)

Rethinking Clinical Trials

Tracy Wang: It is safe to say that none of us predicted COVID, and it hit pretty soon after we started enrollment. Learn more Read about the PROACT Xa study. Discussion Themes -What was your impression of the challenges imposed for doing this trial?

article thumbnail

Sarepta’s Elevidys Reaches Finish Line as First Gene Therapy Approved for Duchenne Muscular Dystrophy

XTalks

million price tag of Elevidys, a one-time gene therapy. It is injected into a patient’s muscle tissue. Elevidys’ approval was based on data from a randomized trial that showed the therapy increased expression of the Elevidys micro-dystrophin protein, which was used as a surrogate endpoint, in DMD patients aged four to five years of age.

article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

On Day 3, Thursday 16 November 2023, the tracks include: the second part of machine learning for protein engineering, antibodies against membrane protein targets, engineering bispecific antibodies, next-generation immunotherapies, protein stability and formulation, and protein process development.

Protein 59
article thumbnail

Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals

XTalks

In 2023, there have been pivotal trends shaping the landscape and application of alpha emitter therapy. They are fundamental in understanding how radiation therapy works in treating cancer and in predicting and managing the side effects of treatments. There have been more than $1.7

DNA 66